NC
AGN

Nicholas Company’s Allergan plc AGN Stock Holding History

Nicholas Company’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-3,199
Closed -$533K – 231
2018
Q2 		$533K Sell
3,199
-52,995
-94% -$8.51M 0.01% 215
2018
Q1 		$9.46M Sell
56,194
-145,631
-72% -$24.4M 0.21% 112
2017
Q4 		$33M Buy
201,825
+56,795
+39% +$10.2M 0.72% 48
2017
Q3 		$29.7M Buy
145,030
+6,500
+5% +$1.51M 0.66% 54
2017
Q2 		$33.7M Buy
138,530
+9,465
+7% +$2.22M 0.75% 51
2017
Q1 		$30.8M Buy
+129,065
New +$30.1M 0.7% 51
2015
Q4 		– Sell
-100
Closed -$27K – 216
2015
Q3 		$27K Buy
+100
New +$30.7K ﹤0.01% 214

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Nicholas Company's AGN Position: Q3 2018 in Review

Nicholas Company sold out of Allergan plc (AGN) in Q3 2018, closing a stake of 3,199 shares — an estimated $533K sold.

Nicholas Company first reported a position in AGN in Q3 2015 and held it in 7 quarters. The position peaked at $33.7M in Q2 2017. 1,067 funds tracked by Wall St. Rank hold AGN as of Q3 2018.

  • Nicholas Company reported no remaining Allergan plc position as of Q3 2018 after selling out during the quarter.
  • Nicholas Company sold 3,199 Allergan plc shares in Q3 2018, an estimated $533K.
  • Nicholas Company first reported a position in Allergan plc in Q3 2015 and held it in 7 quarters.
  • Nicholas Company's Allergan plc position peaked at $33.7M in Q2 2017.
  • 1,067 funds tracked by Wall St. Rank held Allergan plc as of Q3 2018.

Based on Nicholas Company's 13F filing for Q3 2018, filed 14 Nov 2018.